Performance of seven commercial automated assays for the detection of low levels of anti-Toxoplasma IgG in French immunocompromised patients Article Swipe
Tiphaine Douet
,
Catherine Armengol
,
Éléna Charpentier
,
Pamela Chauvin
,
Sophie Cassaing
,
Xavier Iriart
,
Antoine Berry
,
Judith Fillaux
·
YOU?
·
· 2019
· Open Access
·
· DOI: https://doi.org/10.1051/parasite/2019052
YOU?
·
· 2019
· Open Access
·
· DOI: https://doi.org/10.1051/parasite/2019052
Background : Immunocompromised patients are at high risk for the development of severe toxoplasmosis from tissue cyst reactivation, the most frequently, or from recently acquired acute infections. Knowledge of serologic status is therefore crucial. Screening for toxoplasmosis is sometimes performed while patients are already immunocompromised and have a low or even undetectable IgG titer by routine automated enzyme immunoassays. The aim of this study was to assess the sensitivity and specificity of seven reagents for the detection of low levels of IgG. Sera from 354 patients were collected and analysed. Results : Elecsys ® offered the best analytic performances, superior to those of Architect ® and Platelia ® , which were superior to those of Access II ® and TGS TA ® . Vidas II ® and Liaison II ® reagents exhibited poor analytical performances in this cohort. For Elecsys ® , Platelia ® and Architect ® , new thresholds for the grey zone and positive zone have been defined to improve the sensitivity of these reagents while maintaining excellent specificity. Conclusions : Commercialized assays for toxoplasmosis screening are not suitable for IgG low-level detection in patients without adapting the supplier thresholds to avoid false negative results and risk generalized toxoplasmosis.
Related Topics
Metadata
- Type
- article
- Language
- en
- Landing Page
- https://doi.org/10.1051/parasite/2019052
- https://www.parasite-journal.org/articles/parasite/pdf/2019/01/parasite190045.pdf
- OA Status
- gold
- Cited By
- 18
- References
- 16
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W2969736091
All OpenAlex metadata
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W2969736091Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.1051/parasite/2019052Digital Object Identifier
- Title
-
Performance of seven commercial automated assays for the detection of low levels of anti-Toxoplasma IgG in French immunocompromised patientsWork title
- Type
-
articleOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2019Year of publication
- Publication date
-
2019-01-01Full publication date if available
- Authors
-
Tiphaine Douet, Catherine Armengol, Éléna Charpentier, Pamela Chauvin, Sophie Cassaing, Xavier Iriart, Antoine Berry, Judith FillauxList of authors in order
- Landing page
-
https://doi.org/10.1051/parasite/2019052Publisher landing page
- PDF URL
-
https://www.parasite-journal.org/articles/parasite/pdf/2019/01/parasite190045.pdfDirect link to full text PDF
- Open access
-
YesWhether a free full text is available
- OA status
-
goldOpen access status per OpenAlex
- OA URL
-
https://www.parasite-journal.org/articles/parasite/pdf/2019/01/parasite190045.pdfDirect OA link when available
- Concepts
-
Toxoplasmosis, Serology, Titer, Immunology, Biology, Immunoassay, Medicine, Virology, AntibodyTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
18Total citation count in OpenAlex
- Citations by year (recent)
-
2024: 2, 2023: 5, 2022: 5, 2021: 4, 2020: 2Per-year citation counts (last 5 years)
- References (count)
-
16Number of works referenced by this work
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W2969736091 |
|---|---|
| doi | https://doi.org/10.1051/parasite/2019052 |
| ids.doi | https://doi.org/10.1051/parasite/2019052 |
| ids.mag | 2969736091 |
| ids.pmid | https://pubmed.ncbi.nlm.nih.gov/31441775 |
| ids.openalex | https://openalex.org/W2969736091 |
| fwci | 2.09326889 |
| mesh[0].qualifier_ui | |
| mesh[0].descriptor_ui | D000328 |
| mesh[0].is_major_topic | False |
| mesh[0].qualifier_name | |
| mesh[0].descriptor_name | Adult |
| mesh[1].qualifier_ui | Q000097 |
| mesh[1].descriptor_ui | D000913 |
| mesh[1].is_major_topic | False |
| mesh[1].qualifier_name | blood |
| mesh[1].descriptor_name | Antibodies, Protozoan |
| mesh[2].qualifier_ui | Q000592 |
| mesh[2].descriptor_ui | D057205 |
| mesh[2].is_major_topic | False |
| mesh[2].qualifier_name | standards |
| mesh[2].descriptor_name | Automation, Laboratory |
| mesh[3].qualifier_ui | |
| mesh[3].descriptor_ui | D005260 |
| mesh[3].is_major_topic | False |
| mesh[3].qualifier_name | |
| mesh[3].descriptor_name | Female |
| mesh[4].qualifier_ui | |
| mesh[4].descriptor_ui | D006801 |
| mesh[4].is_major_topic | False |
| mesh[4].qualifier_name | |
| mesh[4].descriptor_name | Humans |
| mesh[5].qualifier_ui | |
| mesh[5].descriptor_ui | D016867 |
| mesh[5].is_major_topic | True |
| mesh[5].qualifier_name | |
| mesh[5].descriptor_name | Immunocompromised Host |
| mesh[6].qualifier_ui | Q000097 |
| mesh[6].descriptor_ui | D007074 |
| mesh[6].is_major_topic | False |
| mesh[6].qualifier_name | blood |
| mesh[6].descriptor_name | Immunoglobulin G |
| mesh[7].qualifier_ui | |
| mesh[7].descriptor_ui | D008297 |
| mesh[7].is_major_topic | False |
| mesh[7].qualifier_name | |
| mesh[7].descriptor_name | Male |
| mesh[8].qualifier_ui | |
| mesh[8].descriptor_ui | D008403 |
| mesh[8].is_major_topic | False |
| mesh[8].qualifier_name | |
| mesh[8].descriptor_name | Mass Screening |
| mesh[9].qualifier_ui | |
| mesh[9].descriptor_ui | D008875 |
| mesh[9].is_major_topic | False |
| mesh[9].qualifier_name | |
| mesh[9].descriptor_name | Middle Aged |
| mesh[10].qualifier_ui | Q000592 |
| mesh[10].descriptor_ui | D011933 |
| mesh[10].is_major_topic | False |
| mesh[10].qualifier_name | standards |
| mesh[10].descriptor_name | Reagent Kits, Diagnostic |
| mesh[11].qualifier_ui | |
| mesh[11].descriptor_ui | D012680 |
| mesh[11].is_major_topic | False |
| mesh[11].qualifier_name | |
| mesh[11].descriptor_name | Sensitivity and Specificity |
| mesh[12].qualifier_ui | Q000592 |
| mesh[12].descriptor_ui | D012698 |
| mesh[12].is_major_topic | False |
| mesh[12].qualifier_name | standards |
| mesh[12].descriptor_name | Serologic Tests |
| mesh[13].qualifier_ui | Q000276 |
| mesh[13].descriptor_ui | D014122 |
| mesh[13].is_major_topic | False |
| mesh[13].qualifier_name | immunology |
| mesh[13].descriptor_name | Toxoplasma |
| mesh[14].qualifier_ui | Q000175 |
| mesh[14].descriptor_ui | D014123 |
| mesh[14].is_major_topic | False |
| mesh[14].qualifier_name | diagnosis |
| mesh[14].descriptor_name | Toxoplasmosis |
| mesh[15].qualifier_ui | Q000276 |
| mesh[15].descriptor_ui | D014123 |
| mesh[15].is_major_topic | False |
| mesh[15].qualifier_name | immunology |
| mesh[15].descriptor_name | Toxoplasmosis |
| mesh[16].qualifier_ui | |
| mesh[16].descriptor_ui | D055815 |
| mesh[16].is_major_topic | False |
| mesh[16].qualifier_name | |
| mesh[16].descriptor_name | Young Adult |
| mesh[17].qualifier_ui | |
| mesh[17].descriptor_ui | D000328 |
| mesh[17].is_major_topic | False |
| mesh[17].qualifier_name | |
| mesh[17].descriptor_name | Adult |
| mesh[18].qualifier_ui | Q000097 |
| mesh[18].descriptor_ui | D000913 |
| mesh[18].is_major_topic | False |
| mesh[18].qualifier_name | blood |
| mesh[18].descriptor_name | Antibodies, Protozoan |
| mesh[19].qualifier_ui | Q000592 |
| mesh[19].descriptor_ui | D057205 |
| mesh[19].is_major_topic | False |
| mesh[19].qualifier_name | standards |
| mesh[19].descriptor_name | Automation, Laboratory |
| mesh[20].qualifier_ui | |
| mesh[20].descriptor_ui | D005260 |
| mesh[20].is_major_topic | False |
| mesh[20].qualifier_name | |
| mesh[20].descriptor_name | Female |
| mesh[21].qualifier_ui | |
| mesh[21].descriptor_ui | D006801 |
| mesh[21].is_major_topic | False |
| mesh[21].qualifier_name | |
| mesh[21].descriptor_name | Humans |
| mesh[22].qualifier_ui | |
| mesh[22].descriptor_ui | D016867 |
| mesh[22].is_major_topic | True |
| mesh[22].qualifier_name | |
| mesh[22].descriptor_name | Immunocompromised Host |
| mesh[23].qualifier_ui | Q000097 |
| mesh[23].descriptor_ui | D007074 |
| mesh[23].is_major_topic | False |
| mesh[23].qualifier_name | blood |
| mesh[23].descriptor_name | Immunoglobulin G |
| mesh[24].qualifier_ui | |
| mesh[24].descriptor_ui | D008297 |
| mesh[24].is_major_topic | False |
| mesh[24].qualifier_name | |
| mesh[24].descriptor_name | Male |
| mesh[25].qualifier_ui | |
| mesh[25].descriptor_ui | D008403 |
| mesh[25].is_major_topic | False |
| mesh[25].qualifier_name | |
| mesh[25].descriptor_name | Mass Screening |
| mesh[26].qualifier_ui | |
| mesh[26].descriptor_ui | D008875 |
| mesh[26].is_major_topic | False |
| mesh[26].qualifier_name | |
| mesh[26].descriptor_name | Middle Aged |
| mesh[27].qualifier_ui | Q000592 |
| mesh[27].descriptor_ui | D011933 |
| mesh[27].is_major_topic | False |
| mesh[27].qualifier_name | standards |
| mesh[27].descriptor_name | Reagent Kits, Diagnostic |
| mesh[28].qualifier_ui | |
| mesh[28].descriptor_ui | D012680 |
| mesh[28].is_major_topic | False |
| mesh[28].qualifier_name | |
| mesh[28].descriptor_name | Sensitivity and Specificity |
| mesh[29].qualifier_ui | Q000592 |
| mesh[29].descriptor_ui | D012698 |
| mesh[29].is_major_topic | False |
| mesh[29].qualifier_name | standards |
| mesh[29].descriptor_name | Serologic Tests |
| mesh[30].qualifier_ui | Q000276 |
| mesh[30].descriptor_ui | D014122 |
| mesh[30].is_major_topic | False |
| mesh[30].qualifier_name | immunology |
| mesh[30].descriptor_name | Toxoplasma |
| mesh[31].qualifier_ui | Q000175 |
| mesh[31].descriptor_ui | D014123 |
| mesh[31].is_major_topic | False |
| mesh[31].qualifier_name | diagnosis |
| mesh[31].descriptor_name | Toxoplasmosis |
| mesh[32].qualifier_ui | Q000276 |
| mesh[32].descriptor_ui | D014123 |
| mesh[32].is_major_topic | False |
| mesh[32].qualifier_name | immunology |
| mesh[32].descriptor_name | Toxoplasmosis |
| mesh[33].qualifier_ui | |
| mesh[33].descriptor_ui | D055815 |
| mesh[33].is_major_topic | False |
| mesh[33].qualifier_name | |
| mesh[33].descriptor_name | Young Adult |
| mesh[34].qualifier_ui | |
| mesh[34].descriptor_ui | D000328 |
| mesh[34].is_major_topic | False |
| mesh[34].qualifier_name | |
| mesh[34].descriptor_name | Adult |
| mesh[35].qualifier_ui | Q000097 |
| mesh[35].descriptor_ui | D000913 |
| mesh[35].is_major_topic | False |
| mesh[35].qualifier_name | blood |
| mesh[35].descriptor_name | Antibodies, Protozoan |
| mesh[36].qualifier_ui | Q000592 |
| mesh[36].descriptor_ui | D057205 |
| mesh[36].is_major_topic | False |
| mesh[36].qualifier_name | standards |
| mesh[36].descriptor_name | Automation, Laboratory |
| mesh[37].qualifier_ui | |
| mesh[37].descriptor_ui | D005260 |
| mesh[37].is_major_topic | False |
| mesh[37].qualifier_name | |
| mesh[37].descriptor_name | Female |
| mesh[38].qualifier_ui | |
| mesh[38].descriptor_ui | D006801 |
| mesh[38].is_major_topic | False |
| mesh[38].qualifier_name | |
| mesh[38].descriptor_name | Humans |
| mesh[39].qualifier_ui | |
| mesh[39].descriptor_ui | D016867 |
| mesh[39].is_major_topic | True |
| mesh[39].qualifier_name | |
| mesh[39].descriptor_name | Immunocompromised Host |
| mesh[40].qualifier_ui | Q000097 |
| mesh[40].descriptor_ui | D007074 |
| mesh[40].is_major_topic | False |
| mesh[40].qualifier_name | blood |
| mesh[40].descriptor_name | Immunoglobulin G |
| mesh[41].qualifier_ui | |
| mesh[41].descriptor_ui | D008297 |
| mesh[41].is_major_topic | False |
| mesh[41].qualifier_name | |
| mesh[41].descriptor_name | Male |
| mesh[42].qualifier_ui | |
| mesh[42].descriptor_ui | D008403 |
| mesh[42].is_major_topic | False |
| mesh[42].qualifier_name | |
| mesh[42].descriptor_name | Mass Screening |
| mesh[43].qualifier_ui | |
| mesh[43].descriptor_ui | D008875 |
| mesh[43].is_major_topic | False |
| mesh[43].qualifier_name | |
| mesh[43].descriptor_name | Middle Aged |
| mesh[44].qualifier_ui | Q000592 |
| mesh[44].descriptor_ui | D011933 |
| mesh[44].is_major_topic | False |
| mesh[44].qualifier_name | standards |
| mesh[44].descriptor_name | Reagent Kits, Diagnostic |
| mesh[45].qualifier_ui | |
| mesh[45].descriptor_ui | D012680 |
| mesh[45].is_major_topic | False |
| mesh[45].qualifier_name | |
| mesh[45].descriptor_name | Sensitivity and Specificity |
| mesh[46].qualifier_ui | Q000592 |
| mesh[46].descriptor_ui | D012698 |
| mesh[46].is_major_topic | False |
| mesh[46].qualifier_name | standards |
| mesh[46].descriptor_name | Serologic Tests |
| mesh[47].qualifier_ui | Q000276 |
| mesh[47].descriptor_ui | D014122 |
| mesh[47].is_major_topic | False |
| mesh[47].qualifier_name | immunology |
| mesh[47].descriptor_name | Toxoplasma |
| mesh[48].qualifier_ui | Q000175 |
| mesh[48].descriptor_ui | D014123 |
| mesh[48].is_major_topic | False |
| mesh[48].qualifier_name | diagnosis |
| mesh[48].descriptor_name | Toxoplasmosis |
| mesh[49].qualifier_ui | Q000276 |
| mesh[49].descriptor_ui | D014123 |
| mesh[49].is_major_topic | False |
| mesh[49].qualifier_name | immunology |
| mesh[49].descriptor_name | Toxoplasmosis |
| type | article |
| title | Performance of seven commercial automated assays for the detection of low levels of anti-Toxoplasma IgG in French immunocompromised patients |
| biblio.issue | |
| biblio.volume | 26 |
| biblio.last_page | 51 |
| biblio.first_page | 51 |
| topics[0].id | https://openalex.org/T11155 |
| topics[0].field.id | https://openalex.org/fields/24 |
| topics[0].field.display_name | Immunology and Microbiology |
| topics[0].score | 1.0 |
| topics[0].domain.id | https://openalex.org/domains/1 |
| topics[0].domain.display_name | Life Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/2405 |
| topics[0].subfield.display_name | Parasitology |
| topics[0].display_name | Toxoplasma gondii Research Studies |
| topics[1].id | https://openalex.org/T11780 |
| topics[1].field.id | https://openalex.org/fields/24 |
| topics[1].field.display_name | Immunology and Microbiology |
| topics[1].score | 0.9962999820709229 |
| topics[1].domain.id | https://openalex.org/domains/1 |
| topics[1].domain.display_name | Life Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/2406 |
| topics[1].subfield.display_name | Virology |
| topics[1].display_name | Rabies epidemiology and control |
| topics[2].id | https://openalex.org/T10625 |
| topics[2].field.id | https://openalex.org/fields/27 |
| topics[2].field.display_name | Medicine |
| topics[2].score | 0.991599977016449 |
| topics[2].domain.id | https://openalex.org/domains/4 |
| topics[2].domain.display_name | Health Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/2713 |
| topics[2].subfield.display_name | Epidemiology |
| topics[2].display_name | Herpesvirus Infections and Treatments |
| is_xpac | False |
| apc_list.value | 900 |
| apc_list.currency | EUR |
| apc_list.value_usd | 970 |
| apc_paid.value | 900 |
| apc_paid.currency | EUR |
| apc_paid.value_usd | 970 |
| concepts[0].id | https://openalex.org/C2778062946 |
| concepts[0].level | 2 |
| concepts[0].score | 0.758032500743866 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q154878 |
| concepts[0].display_name | Toxoplasmosis |
| concepts[1].id | https://openalex.org/C45189115 |
| concepts[1].level | 3 |
| concepts[1].score | 0.6683602333068848 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q502159 |
| concepts[1].display_name | Serology |
| concepts[2].id | https://openalex.org/C32611913 |
| concepts[2].level | 3 |
| concepts[2].score | 0.5357303619384766 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q2166189 |
| concepts[2].display_name | Titer |
| concepts[3].id | https://openalex.org/C203014093 |
| concepts[3].level | 1 |
| concepts[3].score | 0.4661746025085449 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q101929 |
| concepts[3].display_name | Immunology |
| concepts[4].id | https://openalex.org/C86803240 |
| concepts[4].level | 0 |
| concepts[4].score | 0.4582473635673523 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q420 |
| concepts[4].display_name | Biology |
| concepts[5].id | https://openalex.org/C2780420688 |
| concepts[5].level | 3 |
| concepts[5].score | 0.4353106617927551 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q759183 |
| concepts[5].display_name | Immunoassay |
| concepts[6].id | https://openalex.org/C71924100 |
| concepts[6].level | 0 |
| concepts[6].score | 0.35979020595550537 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q11190 |
| concepts[6].display_name | Medicine |
| concepts[7].id | https://openalex.org/C159047783 |
| concepts[7].level | 1 |
| concepts[7].score | 0.3515512943267822 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q7215 |
| concepts[7].display_name | Virology |
| concepts[8].id | https://openalex.org/C159654299 |
| concepts[8].level | 2 |
| concepts[8].score | 0.2399139404296875 |
| concepts[8].wikidata | https://www.wikidata.org/wiki/Q79460 |
| concepts[8].display_name | Antibody |
| keywords[0].id | https://openalex.org/keywords/toxoplasmosis |
| keywords[0].score | 0.758032500743866 |
| keywords[0].display_name | Toxoplasmosis |
| keywords[1].id | https://openalex.org/keywords/serology |
| keywords[1].score | 0.6683602333068848 |
| keywords[1].display_name | Serology |
| keywords[2].id | https://openalex.org/keywords/titer |
| keywords[2].score | 0.5357303619384766 |
| keywords[2].display_name | Titer |
| keywords[3].id | https://openalex.org/keywords/immunology |
| keywords[3].score | 0.4661746025085449 |
| keywords[3].display_name | Immunology |
| keywords[4].id | https://openalex.org/keywords/biology |
| keywords[4].score | 0.4582473635673523 |
| keywords[4].display_name | Biology |
| keywords[5].id | https://openalex.org/keywords/immunoassay |
| keywords[5].score | 0.4353106617927551 |
| keywords[5].display_name | Immunoassay |
| keywords[6].id | https://openalex.org/keywords/medicine |
| keywords[6].score | 0.35979020595550537 |
| keywords[6].display_name | Medicine |
| keywords[7].id | https://openalex.org/keywords/virology |
| keywords[7].score | 0.3515512943267822 |
| keywords[7].display_name | Virology |
| keywords[8].id | https://openalex.org/keywords/antibody |
| keywords[8].score | 0.2399139404296875 |
| keywords[8].display_name | Antibody |
| language | en |
| locations[0].id | doi:10.1051/parasite/2019052 |
| locations[0].is_oa | True |
| locations[0].source.id | https://openalex.org/S51637054 |
| locations[0].source.issn | 1252-607X, 1776-1042 |
| locations[0].source.type | journal |
| locations[0].source.is_oa | True |
| locations[0].source.issn_l | 1252-607X |
| locations[0].source.is_core | True |
| locations[0].source.is_in_doaj | True |
| locations[0].source.display_name | Parasite |
| locations[0].source.host_organization | https://openalex.org/P4310319748 |
| locations[0].source.host_organization_name | EDP Sciences |
| locations[0].source.host_organization_lineage | https://openalex.org/P4310319748 |
| locations[0].license | cc-by |
| locations[0].pdf_url | https://www.parasite-journal.org/articles/parasite/pdf/2019/01/parasite190045.pdf |
| locations[0].version | publishedVersion |
| locations[0].raw_type | journal-article |
| locations[0].license_id | https://openalex.org/licenses/cc-by |
| locations[0].is_accepted | True |
| locations[0].is_published | True |
| locations[0].raw_source_name | Parasite |
| locations[0].landing_page_url | https://doi.org/10.1051/parasite/2019052 |
| locations[1].id | pmid:31441775 |
| locations[1].is_oa | False |
| locations[1].source.id | https://openalex.org/S4306525036 |
| locations[1].source.issn | |
| locations[1].source.type | repository |
| locations[1].source.is_oa | False |
| locations[1].source.issn_l | |
| locations[1].source.is_core | False |
| locations[1].source.is_in_doaj | False |
| locations[1].source.display_name | PubMed |
| locations[1].source.host_organization | https://openalex.org/I1299303238 |
| locations[1].source.host_organization_name | National Institutes of Health |
| locations[1].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[1].license | |
| locations[1].pdf_url | |
| locations[1].version | publishedVersion |
| locations[1].raw_type | |
| locations[1].license_id | |
| locations[1].is_accepted | True |
| locations[1].is_published | True |
| locations[1].raw_source_name | Parasite (Paris, France) |
| locations[1].landing_page_url | https://pubmed.ncbi.nlm.nih.gov/31441775 |
| locations[2].id | pmh:oai:HAL:hal-02968680v1 |
| locations[2].is_oa | True |
| locations[2].source.id | https://openalex.org/S4306402512 |
| locations[2].source.issn | |
| locations[2].source.type | repository |
| locations[2].source.is_oa | False |
| locations[2].source.issn_l | |
| locations[2].source.is_core | False |
| locations[2].source.is_in_doaj | False |
| locations[2].source.display_name | HAL (Le Centre pour la Communication Scientifique Directe) |
| locations[2].source.host_organization | https://openalex.org/I1294671590 |
| locations[2].source.host_organization_name | Centre National de la Recherche Scientifique |
| locations[2].source.host_organization_lineage | https://openalex.org/I1294671590 |
| locations[2].license | cc-by |
| locations[2].pdf_url | |
| locations[2].version | submittedVersion |
| locations[2].raw_type | Journal articles |
| locations[2].license_id | https://openalex.org/licenses/cc-by |
| locations[2].is_accepted | False |
| locations[2].is_published | False |
| locations[2].raw_source_name | Parasite, 2019, 26 (51), pp.1-8. ⟨10.1051/parasite/2019052⟩ |
| locations[2].landing_page_url | https://hal.science/hal-02968680 |
| locations[3].id | pmh:oai:doaj.org/article:7ebce4a011ae49dda939a964c3f05364 |
| locations[3].is_oa | False |
| locations[3].source.id | https://openalex.org/S4306401280 |
| locations[3].source.issn | |
| locations[3].source.type | repository |
| locations[3].source.is_oa | False |
| locations[3].source.issn_l | |
| locations[3].source.is_core | False |
| locations[3].source.is_in_doaj | False |
| locations[3].source.display_name | DOAJ (DOAJ: Directory of Open Access Journals) |
| locations[3].source.host_organization | |
| locations[3].source.host_organization_name | |
| locations[3].source.host_organization_lineage | |
| locations[3].license | |
| locations[3].pdf_url | |
| locations[3].version | submittedVersion |
| locations[3].raw_type | article |
| locations[3].license_id | |
| locations[3].is_accepted | False |
| locations[3].is_published | False |
| locations[3].raw_source_name | Parasite, Vol 26, p 51 (2019) |
| locations[3].landing_page_url | https://doaj.org/article/7ebce4a011ae49dda939a964c3f05364 |
| locations[4].id | pmh:oai:pubmedcentral.nih.gov:6707100 |
| locations[4].is_oa | True |
| locations[4].source.id | https://openalex.org/S2764455111 |
| locations[4].source.issn | |
| locations[4].source.type | repository |
| locations[4].source.is_oa | False |
| locations[4].source.issn_l | |
| locations[4].source.is_core | False |
| locations[4].source.is_in_doaj | False |
| locations[4].source.display_name | PubMed Central |
| locations[4].source.host_organization | https://openalex.org/I1299303238 |
| locations[4].source.host_organization_name | National Institutes of Health |
| locations[4].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[4].license | other-oa |
| locations[4].pdf_url | |
| locations[4].version | submittedVersion |
| locations[4].raw_type | Text |
| locations[4].license_id | https://openalex.org/licenses/other-oa |
| locations[4].is_accepted | False |
| locations[4].is_published | False |
| locations[4].raw_source_name | Parasite |
| locations[4].landing_page_url | https://www.ncbi.nlm.nih.gov/pmc/articles/6707100 |
| indexed_in | crossref, doaj, pubmed |
| authorships[0].author.id | https://openalex.org/A5031689333 |
| authorships[0].author.orcid | |
| authorships[0].author.display_name | Tiphaine Douet |
| authorships[0].affiliations[0].raw_affiliation_string | Service de Parasitologie et Mycologie [CHU Toulouse] (Pôle Biologie - 330, avenue de Grande-Bretagne - TSA 40031 - 31059 Toulouse cedex 9 - France) |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Tiphaine Douet |
| authorships[0].is_corresponding | False |
| authorships[0].raw_affiliation_strings | Service de Parasitologie et Mycologie [CHU Toulouse] (Pôle Biologie - 330, avenue de Grande-Bretagne - TSA 40031 - 31059 Toulouse cedex 9 - France) |
| authorships[1].author.id | https://openalex.org/A5025626825 |
| authorships[1].author.orcid | |
| authorships[1].author.display_name | Catherine Armengol |
| authorships[1].affiliations[0].raw_affiliation_string | Service de Parasitologie et Mycologie [CHU Toulouse] (Pôle Biologie - 330, avenue de Grande-Bretagne - TSA 40031 - 31059 Toulouse cedex 9 - France) |
| authorships[1].affiliations[1].raw_affiliation_string | CHCP - Centre Hospitalier Comminges Pyrénées (Avenue de Saint Plancard, 31806 SAINT GAUDENS - France) |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Catherine Armengol |
| authorships[1].is_corresponding | False |
| authorships[1].raw_affiliation_strings | CHCP - Centre Hospitalier Comminges Pyrénées (Avenue de Saint Plancard, 31806 SAINT GAUDENS - France), Service de Parasitologie et Mycologie [CHU Toulouse] (Pôle Biologie - 330, avenue de Grande-Bretagne - TSA 40031 - 31059 Toulouse cedex 9 - France) |
| authorships[2].author.id | https://openalex.org/A5038036154 |
| authorships[2].author.orcid | |
| authorships[2].author.display_name | Éléna Charpentier |
| authorships[2].affiliations[0].raw_affiliation_string | Service de Parasitologie et Mycologie [CHU Toulouse] (Pôle Biologie - 330, avenue de Grande-Bretagne - TSA 40031 - 31059 Toulouse cedex 9 - France) |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Elena Charpentier |
| authorships[2].is_corresponding | False |
| authorships[2].raw_affiliation_strings | Service de Parasitologie et Mycologie [CHU Toulouse] (Pôle Biologie - 330, avenue de Grande-Bretagne - TSA 40031 - 31059 Toulouse cedex 9 - France) |
| authorships[3].author.id | https://openalex.org/A5104036150 |
| authorships[3].author.orcid | |
| authorships[3].author.display_name | Pamela Chauvin |
| authorships[3].affiliations[0].raw_affiliation_string | Service de Parasitologie et Mycologie [CHU Toulouse] (Pôle Biologie - 330, avenue de Grande-Bretagne - TSA 40031 - 31059 Toulouse cedex 9 - France) |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | Pamela Chauvin |
| authorships[3].is_corresponding | False |
| authorships[3].raw_affiliation_strings | Service de Parasitologie et Mycologie [CHU Toulouse] (Pôle Biologie - 330, avenue de Grande-Bretagne - TSA 40031 - 31059 Toulouse cedex 9 - France) |
| authorships[4].author.id | https://openalex.org/A5039278700 |
| authorships[4].author.orcid | https://orcid.org/0000-0003-0055-0136 |
| authorships[4].author.display_name | Sophie Cassaing |
| authorships[4].countries | FR |
| authorships[4].affiliations[0].raw_affiliation_string | Service de Parasitologie et Mycologie [CHU Toulouse] (Pôle Biologie - 330, avenue de Grande-Bretagne - TSA 40031 - 31059 Toulouse cedex 9 - France) |
| authorships[4].affiliations[1].institution_ids | https://openalex.org/I134560555, https://openalex.org/I4210140430, https://openalex.org/I4210166444 |
| authorships[4].affiliations[1].raw_affiliation_string | PHARMA-DEV - Pharmacochimie et Biologie pour le Développement (IRD UMR 152 Université Paul Sabatier 35 Chemin des Maraîchers 31400 Toulouse - France) |
| authorships[4].institutions[0].id | https://openalex.org/I4210166444 |
| authorships[4].institutions[0].ror | https://ror.org/05q3vnk25 |
| authorships[4].institutions[0].type | government |
| authorships[4].institutions[0].lineage | https://openalex.org/I2802818602, https://openalex.org/I4210090127, https://openalex.org/I4210131494, https://openalex.org/I4210166444 |
| authorships[4].institutions[0].country_code | FR |
| authorships[4].institutions[0].display_name | Institut de Recherche pour le Développement |
| authorships[4].institutions[1].id | https://openalex.org/I4210140430 |
| authorships[4].institutions[1].ror | https://ror.org/03p7xrr08 |
| authorships[4].institutions[1].type | facility |
| authorships[4].institutions[1].lineage | https://openalex.org/I134560555, https://openalex.org/I2802818602, https://openalex.org/I4210090127, https://openalex.org/I4210131494, https://openalex.org/I4210140430, https://openalex.org/I4210166444, https://openalex.org/I4412460029 |
| authorships[4].institutions[1].country_code | FR |
| authorships[4].institutions[1].display_name | Pharmacochimie et Pharmacologie pour le Développement |
| authorships[4].institutions[2].id | https://openalex.org/I134560555 |
| authorships[4].institutions[2].ror | https://ror.org/02v6kpv12 |
| authorships[4].institutions[2].type | education |
| authorships[4].institutions[2].lineage | https://openalex.org/I134560555, https://openalex.org/I4412460029 |
| authorships[4].institutions[2].country_code | FR |
| authorships[4].institutions[2].display_name | Université Toulouse III - Paul Sabatier |
| authorships[4].author_position | middle |
| authorships[4].raw_author_name | Sophie Cassaing |
| authorships[4].is_corresponding | False |
| authorships[4].raw_affiliation_strings | PHARMA-DEV - Pharmacochimie et Biologie pour le Développement (IRD UMR 152 Université Paul Sabatier 35 Chemin des Maraîchers 31400 Toulouse - France), Service de Parasitologie et Mycologie [CHU Toulouse] (Pôle Biologie - 330, avenue de Grande-Bretagne - TSA 40031 - 31059 Toulouse cedex 9 - France) |
| authorships[5].author.id | https://openalex.org/A5069862680 |
| authorships[5].author.orcid | https://orcid.org/0000-0002-0998-8962 |
| authorships[5].author.display_name | Xavier Iriart |
| authorships[5].affiliations[0].raw_affiliation_string | Service de Parasitologie et Mycologie [CHU Toulouse] (Pôle Biologie - 330, avenue de Grande-Bretagne - TSA 40031 - 31059 Toulouse cedex 9 - France) |
| authorships[5].author_position | middle |
| authorships[5].raw_author_name | Xavier Iriart |
| authorships[5].is_corresponding | False |
| authorships[5].raw_affiliation_strings | Service de Parasitologie et Mycologie [CHU Toulouse] (Pôle Biologie - 330, avenue de Grande-Bretagne - TSA 40031 - 31059 Toulouse cedex 9 - France) |
| authorships[6].author.id | https://openalex.org/A5050142232 |
| authorships[6].author.orcid | https://orcid.org/0000-0002-6626-7766 |
| authorships[6].author.display_name | Antoine Berry |
| authorships[6].affiliations[0].raw_affiliation_string | Service de Parasitologie et Mycologie [CHU Toulouse] (Pôle Biologie - 330, avenue de Grande-Bretagne - TSA 40031 - 31059 Toulouse cedex 9 - France) |
| authorships[6].author_position | middle |
| authorships[6].raw_author_name | Antoine Berry |
| authorships[6].is_corresponding | False |
| authorships[6].raw_affiliation_strings | Service de Parasitologie et Mycologie [CHU Toulouse] (Pôle Biologie - 330, avenue de Grande-Bretagne - TSA 40031 - 31059 Toulouse cedex 9 - France) |
| authorships[7].author.id | https://openalex.org/A5040182237 |
| authorships[7].author.orcid | https://orcid.org/0000-0002-5277-189X |
| authorships[7].author.display_name | Judith Fillaux |
| authorships[7].countries | FR |
| authorships[7].affiliations[0].raw_affiliation_string | Service de Parasitologie et Mycologie [CHU Toulouse] (Pôle Biologie - 330, avenue de Grande-Bretagne - TSA 40031 - 31059 Toulouse cedex 9 - France) |
| authorships[7].affiliations[1].institution_ids | https://openalex.org/I134560555, https://openalex.org/I4210140430, https://openalex.org/I4210166444 |
| authorships[7].affiliations[1].raw_affiliation_string | PHARMA-DEV - Pharmacochimie et Biologie pour le Développement (IRD UMR 152 Université Paul Sabatier 35 Chemin des Maraîchers 31400 Toulouse - France) |
| authorships[7].institutions[0].id | https://openalex.org/I4210166444 |
| authorships[7].institutions[0].ror | https://ror.org/05q3vnk25 |
| authorships[7].institutions[0].type | government |
| authorships[7].institutions[0].lineage | https://openalex.org/I2802818602, https://openalex.org/I4210090127, https://openalex.org/I4210131494, https://openalex.org/I4210166444 |
| authorships[7].institutions[0].country_code | FR |
| authorships[7].institutions[0].display_name | Institut de Recherche pour le Développement |
| authorships[7].institutions[1].id | https://openalex.org/I4210140430 |
| authorships[7].institutions[1].ror | https://ror.org/03p7xrr08 |
| authorships[7].institutions[1].type | facility |
| authorships[7].institutions[1].lineage | https://openalex.org/I134560555, https://openalex.org/I2802818602, https://openalex.org/I4210090127, https://openalex.org/I4210131494, https://openalex.org/I4210140430, https://openalex.org/I4210166444, https://openalex.org/I4412460029 |
| authorships[7].institutions[1].country_code | FR |
| authorships[7].institutions[1].display_name | Pharmacochimie et Pharmacologie pour le Développement |
| authorships[7].institutions[2].id | https://openalex.org/I134560555 |
| authorships[7].institutions[2].ror | https://ror.org/02v6kpv12 |
| authorships[7].institutions[2].type | education |
| authorships[7].institutions[2].lineage | https://openalex.org/I134560555, https://openalex.org/I4412460029 |
| authorships[7].institutions[2].country_code | FR |
| authorships[7].institutions[2].display_name | Université Toulouse III - Paul Sabatier |
| authorships[7].author_position | last |
| authorships[7].raw_author_name | Judith Fillaux |
| authorships[7].is_corresponding | False |
| authorships[7].raw_affiliation_strings | PHARMA-DEV - Pharmacochimie et Biologie pour le Développement (IRD UMR 152 Université Paul Sabatier 35 Chemin des Maraîchers 31400 Toulouse - France), Service de Parasitologie et Mycologie [CHU Toulouse] (Pôle Biologie - 330, avenue de Grande-Bretagne - TSA 40031 - 31059 Toulouse cedex 9 - France) |
| has_content.pdf | True |
| has_content.grobid_xml | True |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://www.parasite-journal.org/articles/parasite/pdf/2019/01/parasite190045.pdf |
| open_access.oa_status | gold |
| open_access.any_repository_has_fulltext | False |
| created_date | 2019-08-29T00:00:00 |
| display_name | Performance of seven commercial automated assays for the detection of low levels of anti-Toxoplasma IgG in French immunocompromised patients |
| has_fulltext | True |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T11155 |
| primary_topic.field.id | https://openalex.org/fields/24 |
| primary_topic.field.display_name | Immunology and Microbiology |
| primary_topic.score | 1.0 |
| primary_topic.domain.id | https://openalex.org/domains/1 |
| primary_topic.domain.display_name | Life Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/2405 |
| primary_topic.subfield.display_name | Parasitology |
| primary_topic.display_name | Toxoplasma gondii Research Studies |
| related_works | https://openalex.org/W2416534028, https://openalex.org/W1479973262, https://openalex.org/W2483870124, https://openalex.org/W2041388352, https://openalex.org/W1895619740, https://openalex.org/W2348641172, https://openalex.org/W4307633322, https://openalex.org/W2137004571, https://openalex.org/W2271934434, https://openalex.org/W2383392430 |
| cited_by_count | 18 |
| counts_by_year[0].year | 2024 |
| counts_by_year[0].cited_by_count | 2 |
| counts_by_year[1].year | 2023 |
| counts_by_year[1].cited_by_count | 5 |
| counts_by_year[2].year | 2022 |
| counts_by_year[2].cited_by_count | 5 |
| counts_by_year[3].year | 2021 |
| counts_by_year[3].cited_by_count | 4 |
| counts_by_year[4].year | 2020 |
| counts_by_year[4].cited_by_count | 2 |
| locations_count | 5 |
| best_oa_location.id | doi:10.1051/parasite/2019052 |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S51637054 |
| best_oa_location.source.issn | 1252-607X, 1776-1042 |
| best_oa_location.source.type | journal |
| best_oa_location.source.is_oa | True |
| best_oa_location.source.issn_l | 1252-607X |
| best_oa_location.source.is_core | True |
| best_oa_location.source.is_in_doaj | True |
| best_oa_location.source.display_name | Parasite |
| best_oa_location.source.host_organization | https://openalex.org/P4310319748 |
| best_oa_location.source.host_organization_name | EDP Sciences |
| best_oa_location.source.host_organization_lineage | https://openalex.org/P4310319748 |
| best_oa_location.license | cc-by |
| best_oa_location.pdf_url | https://www.parasite-journal.org/articles/parasite/pdf/2019/01/parasite190045.pdf |
| best_oa_location.version | publishedVersion |
| best_oa_location.raw_type | journal-article |
| best_oa_location.license_id | https://openalex.org/licenses/cc-by |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | True |
| best_oa_location.raw_source_name | Parasite |
| best_oa_location.landing_page_url | https://doi.org/10.1051/parasite/2019052 |
| primary_location.id | doi:10.1051/parasite/2019052 |
| primary_location.is_oa | True |
| primary_location.source.id | https://openalex.org/S51637054 |
| primary_location.source.issn | 1252-607X, 1776-1042 |
| primary_location.source.type | journal |
| primary_location.source.is_oa | True |
| primary_location.source.issn_l | 1252-607X |
| primary_location.source.is_core | True |
| primary_location.source.is_in_doaj | True |
| primary_location.source.display_name | Parasite |
| primary_location.source.host_organization | https://openalex.org/P4310319748 |
| primary_location.source.host_organization_name | EDP Sciences |
| primary_location.source.host_organization_lineage | https://openalex.org/P4310319748 |
| primary_location.license | cc-by |
| primary_location.pdf_url | https://www.parasite-journal.org/articles/parasite/pdf/2019/01/parasite190045.pdf |
| primary_location.version | publishedVersion |
| primary_location.raw_type | journal-article |
| primary_location.license_id | https://openalex.org/licenses/cc-by |
| primary_location.is_accepted | True |
| primary_location.is_published | True |
| primary_location.raw_source_name | Parasite |
| primary_location.landing_page_url | https://doi.org/10.1051/parasite/2019052 |
| publication_date | 2019-01-01 |
| publication_year | 2019 |
| referenced_works | https://openalex.org/W2537472220, https://openalex.org/W2102430511, https://openalex.org/W2152426018, https://openalex.org/W2147396176, https://openalex.org/W2008514595, https://openalex.org/W2473258089, https://openalex.org/W2109385305, https://openalex.org/W4211140781, https://openalex.org/W1942169419, https://openalex.org/W1984869616, https://openalex.org/W2136201171, https://openalex.org/W2112038800, https://openalex.org/W2530319597, https://openalex.org/W2914344391, https://openalex.org/W2118261210, https://openalex.org/W2483870124 |
| referenced_works_count | 16 |
| abstract_inverted_index., | 108, 141, 147 |
| abstract_inverted_index.. | 122 |
| abstract_inverted_index.: | 1, 91, 172 |
| abstract_inverted_index.a | 47 |
| abstract_inverted_index.II | 116, 124, 128 |
| abstract_inverted_index.TA | 120 |
| abstract_inverted_index.at | 5 |
| abstract_inverted_index.by | 54 |
| abstract_inverted_index.in | 135, 185 |
| abstract_inverted_index.is | 31, 37 |
| abstract_inverted_index.of | 11, 28, 61, 71, 77, 80, 102, 114, 164 |
| abstract_inverted_index.or | 21, 49 |
| abstract_inverted_index.to | 65, 100, 112, 160, 192 |
| abstract_inverted_index.® | 93, 104, 107, 117, 121, 125, 129, 140, 143, 146 |
| abstract_inverted_index.354 | 84 |
| abstract_inverted_index.For | 138 |
| abstract_inverted_index.IgG | 52, 182 |
| abstract_inverted_index.TGS | 119 |
| abstract_inverted_index.The | 59 |
| abstract_inverted_index.aim | 60 |
| abstract_inverted_index.and | 45, 69, 88, 105, 118, 126, 144, 154, 197 |
| abstract_inverted_index.are | 4, 42, 178 |
| abstract_inverted_index.for | 8, 35, 74, 150, 175, 181 |
| abstract_inverted_index.low | 48, 78 |
| abstract_inverted_index.new | 148 |
| abstract_inverted_index.not | 179 |
| abstract_inverted_index.the | 9, 18, 67, 75, 95, 151, 162, 189 |
| abstract_inverted_index.was | 64 |
| abstract_inverted_index.IgG. | 81 |
| abstract_inverted_index.Sera | 82 |
| abstract_inverted_index.been | 158 |
| abstract_inverted_index.best | 96 |
| abstract_inverted_index.cyst | 16 |
| abstract_inverted_index.even | 50 |
| abstract_inverted_index.from | 14, 22, 83 |
| abstract_inverted_index.grey | 152 |
| abstract_inverted_index.have | 46, 157 |
| abstract_inverted_index.high | 6 |
| abstract_inverted_index.most | 19 |
| abstract_inverted_index.poor | 132 |
| abstract_inverted_index.risk | 7, 198 |
| abstract_inverted_index.this | 62, 136 |
| abstract_inverted_index.were | 86, 110 |
| abstract_inverted_index.zone | 153, 156 |
| abstract_inverted_index.Vidas | 123 |
| abstract_inverted_index.acute | 25 |
| abstract_inverted_index.avoid | 193 |
| abstract_inverted_index.false | 194 |
| abstract_inverted_index.seven | 72 |
| abstract_inverted_index.study | 63 |
| abstract_inverted_index.these | 165 |
| abstract_inverted_index.those | 101, 113 |
| abstract_inverted_index.titer | 53 |
| abstract_inverted_index.which | 109 |
| abstract_inverted_index.while | 40, 167 |
| abstract_inverted_index.Access | 115 |
| abstract_inverted_index.assays | 174 |
| abstract_inverted_index.assess | 66 |
| abstract_inverted_index.enzyme | 57 |
| abstract_inverted_index.levels | 79 |
| abstract_inverted_index.severe | 12 |
| abstract_inverted_index.status | 30 |
| abstract_inverted_index.tissue | 15 |
| abstract_inverted_index.Elecsys | 92, 139 |
| abstract_inverted_index.Liaison | 127 |
| abstract_inverted_index.Results | 90 |
| abstract_inverted_index.already | 43 |
| abstract_inverted_index.cohort. | 137 |
| abstract_inverted_index.defined | 159 |
| abstract_inverted_index.improve | 161 |
| abstract_inverted_index.offered | 94 |
| abstract_inverted_index.results | 196 |
| abstract_inverted_index.routine | 55 |
| abstract_inverted_index.without | 187 |
| abstract_inverted_index.Platelia | 106, 142 |
| abstract_inverted_index.acquired | 24 |
| abstract_inverted_index.adapting | 188 |
| abstract_inverted_index.analytic | 97 |
| abstract_inverted_index.crucial. | 33 |
| abstract_inverted_index.negative | 195 |
| abstract_inverted_index.patients | 3, 41, 85, 186 |
| abstract_inverted_index.positive | 155 |
| abstract_inverted_index.reagents | 73, 130, 166 |
| abstract_inverted_index.recently | 23 |
| abstract_inverted_index.suitable | 180 |
| abstract_inverted_index.superior | 99, 111 |
| abstract_inverted_index.supplier | 190 |
| abstract_inverted_index.Architect | 103, 145 |
| abstract_inverted_index.Knowledge | 27 |
| abstract_inverted_index.Screening | 34 |
| abstract_inverted_index.analysed. | 89 |
| abstract_inverted_index.automated | 56 |
| abstract_inverted_index.collected | 87 |
| abstract_inverted_index.detection | 76, 184 |
| abstract_inverted_index.excellent | 169 |
| abstract_inverted_index.exhibited | 131 |
| abstract_inverted_index.low-level | 183 |
| abstract_inverted_index.performed | 39 |
| abstract_inverted_index.screening | 177 |
| abstract_inverted_index.serologic | 29 |
| abstract_inverted_index.sometimes | 38 |
| abstract_inverted_index.therefore | 32 |
| abstract_inverted_index.Background | 0 |
| abstract_inverted_index.analytical | 133 |
| abstract_inverted_index.thresholds | 149, 191 |
| abstract_inverted_index.Conclusions | 171 |
| abstract_inverted_index.development | 10 |
| abstract_inverted_index.frequently, | 20 |
| abstract_inverted_index.generalized | 199 |
| abstract_inverted_index.infections. | 26 |
| abstract_inverted_index.maintaining | 168 |
| abstract_inverted_index.sensitivity | 68, 163 |
| abstract_inverted_index.specificity | 70 |
| abstract_inverted_index.performances | 134 |
| abstract_inverted_index.specificity. | 170 |
| abstract_inverted_index.undetectable | 51 |
| abstract_inverted_index.immunoassays. | 58 |
| abstract_inverted_index.performances, | 98 |
| abstract_inverted_index.reactivation, | 17 |
| abstract_inverted_index.toxoplasmosis | 13, 36, 176 |
| abstract_inverted_index.Commercialized | 173 |
| abstract_inverted_index.toxoplasmosis. | 200 |
| abstract_inverted_index.Immunocompromised | 2 |
| abstract_inverted_index.immunocompromised | 44 |
| cited_by_percentile_year.max | 98 |
| cited_by_percentile_year.min | 94 |
| countries_distinct_count | 1 |
| institutions_distinct_count | 8 |
| sustainable_development_goals[0].id | https://metadata.un.org/sdg/1 |
| sustainable_development_goals[0].score | 0.41999998688697815 |
| sustainable_development_goals[0].display_name | No poverty |
| citation_normalized_percentile.value | 0.83448716 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | False |